CHLOROACETYL-DL-NORLEUCINE(67206-26-2)
- Name: CHLOROACETYL-DL-NORLEUCINE
- Synonyms:DL-Norleucine,N-(chloroacetyl)-;Norleucine, N-chloroacetyl-, DL- (6CI);N-Chloroacetyl-DL-norleucine;NSC 270562;
- Molecular Formula:C8H14ClNO3
- Molecular Weight:207.65
- CAS Registry Number:67206-26-2
- EINECS:
- Melting Point:113 °C
- Water Solubility:
Other Product
- 67523-80-2/Azetidine, 1,1'-azobis-(9CI)
- 85251-65-6/Beech, Fagus sylvatica, ext.
- 81542-97-4/1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid,7-oxo-3-[[(1E)-2-[(1-oxopropyl)amino]ethenyl]thio]-6-[(1S)-1-(sulfooxy)ethyl]-,(5R,6R)-
- 364776-91-0/Zinc,N-methyl-N-[(9Z)-1-oxo-9-octadecen-1-yl]glycine polypropylene glycol diaminestearate complexes
- 22372-64-1/phosphorus(1+), trifluorohydro-, iridium salt
- 86089-00-1/Stomach, antrum,mucosa, ext.
- 5664-80-2/2-(2,4-dichlorophenoxy)-N-[(1-piperidin-1-ylcyclohexyl)methyl]acetamide
- 156859-08-4/Coccolysin
- 309263-22-7/Iodonium,(3-methylphenyl)phenyl-, ar'-C12-13-branched alkyl derivs.,(OC-6-11)-hexafluoroantimonates(1-)
- 85391-57-7/2-[[4-[(2-bromoallyl)(2-hydroxyethyl)amino]phenyl]azo]-5-nitrobenzonitrile
- 106388-50-5/Protein (human clone l810B gene bcl-2 reduced) (9CI)
- 25880-75-5/platinum(2+) hydrogen chloride 2,3-diaminopropanoate (1:1:2:1)
- 63827-50-9/5H-Pyrido[3',4':4,5]pyrrolo[3,2-b]quinoline-4-carbonitrile,1-amino-6,11-dihydro-3-methoxy-6,6,11-trimethyl-
- 584-49-6/4-Bromo-3-nitrobenzenesulphonicacid
- 131298-45-8/Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with2-((2-aminoethyl)amino)ethanesulfonic acid monosodium salt, 1,4-butanediol, 1,6-diisocyanatohexane, diphenyl carbonate, 1,2-ethanediamine, 1,6-hexanediol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, methyloxirane and oxirane, reaction products with 2-(2-butoxyethoxy)ethanol
- 84057-73-8/Cobaltate(3-),bis[6-amino-5-[(2-hydroxy-3,5-dinitrophenyl)azo]-1-naphthalenesulfonato(3-)]-,trisodium (9CI)
- 20421-29-8/7-Ethylidene-1a,2,3,4,4a,7-hexahydrocyclopent[b]oxireno[c]pyridine
- 5219-85-2/(3,3-dimethyl-3,4-dihydroisoquinolin-1(2H)-ylidene)propanedinitrile
- 114088-54-9/2,4(1H,3H)-Quinazolinedione,3-[2-[4-(5-fluoro-2-methylbenzoyl)-1-piperidinyl]ethyl]-
- 67206-26-2/CHLOROACETYL-DL-NORLEUCINE
- 74100-60-0/(-)-Bremazocine Hydrochloride
- 72259-75-7/Hexanedioic acid, polymer with 2,2-bis((2-propenyloxy)methyl)-1-butanol, 2,5-furandione, oxybis(propanol) and 2,2,4-trimethyl-1,3-pentanediol
- 119347-05-6/2H,6H-Benzo[1,2-b:5,4-b']dipyran-6-one,8-[3,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl]-7,8-dihydro-5-hydroxy-2,2-dimethyl-10-(3-methyl-2-butenyl)-,(8S)- (9CI)
- 2775-38-4/2,4-DICHLORO-THIOBENZAMIDE
- 72236-22-7/N,N-diethyl-3-(hydroxymethyl)benzamide
- 58105-25-2/(1Z)-2-prop-2-en-1-ylcyclohexanone semicarbazone
- 149725-00-8/2,9-Pentano-2H-furo[2,3,4-ef][3]benzoxepin-12-one,3-(acetyloxy)decahydro-4,6,9-trimethyl-13-methylene-,(2R,2aS,3S,4S,5aR,9S,9aR,9bR)-rel- (9CI)
- 59397-13-6/1-(thiophen-2-yl)cyclopentanecarboxamide
- 94113-82-3/Anthracene oil,sulfonated
- 30360-42-0/4,6-bis(dichloromethyl)-N-ethyl-1,3,5-triazin-2-amine